The Oncology Institute, Inc. (TOI)
NASDAQ: TOI · Real-Time Price · USD
2.830
-0.130 (-4.39%)
At close: Mar 30, 2026, 4:00 PM EDT
2.820
-0.010 (-0.35%)
After-hours: Mar 30, 2026, 4:53 PM EDT

The Oncology Institute Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-60.61-64.66-83.070.15-10.93
Depreciation & Amortization
6.946.295.874.413.34
Stock-Based Compensation
4.5511.1517.8127.6824.54
Other Adjustments
23.22.6320.71-73.46-35.14
Change in Receivables
-12.58-5.77-4.5-19.67-2.99
Changes in Inventories
-6.843.64-4.39-1.73-1.84
Changes in Accounts Payable
19.649.225.06-6.192.92
Changes in Accrued Expenses
-0.459.473.362.35-3.08
Changes in Income Taxes Payable
---0.260.12-1.01
Changes in Other Operating Activities
1.551.53.084.57-8.48
Operating Cash Flow
-24.59-26.54-36.32-61.76-32.68
Capital Expenditures
-3.2-3.79-4.57-5.53-2.85
Sale of Property, Plant & Equipment
0.13----
Purchases of Intangible Assets
-----0.2
Purchases of Investments
---9.6-117.51-
Proceeds from Sale of Investments
-5081.26--
Payments for Business Acquisitions
---4.46-8.58-9.11
Investing Cash Flow
-3.0746.2162.64-131.61-12.15
Long-Term Debt Issued
---110-
Long-Term Debt Repaid
-20----7.22
Net Long-Term Debt Issued (Repaid)
-20--110-7.22
Issuance of Common Stock
32.640.080.130.86333.95
Repurchase of Common Stock
---1.02-9-
Net Common Stock Issued (Repurchased)
32.640.08-0.89-8.14333.95
Issuance of Preferred Stock
----20
Net Preferred Stock Issued (Repurchased)
----20
Other Financing Activities
-1.08-3.57-5.95-9.65-192.72
Financing Cash Flow
11.56-3.49-6.8592.21154.01
Net Cash Flow
-16.116.1819.48-101.16109.18
Free Cash Flow
-27.79-30.33-40.88-67.29-35.53
FCF Margin
-5.53%-7.71%-12.61%-26.65%-17.50%
Free Cash Flow Per Share
-0.30-0.40-0.55-0.83-0.54
Levered Free Cash Flow
-52.65-26.68-59.71108.07-28.86
Unlevered Free Cash Flow
-18.51-33.79-68.89134.89-59.52
Updated Mar 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q